The genetics of coronary heart disease

British Medical Bulletin
Daniel I SwerdlowSteve E Humphries

Abstract

Coronary heart disease (CHD) is a leading cause of death worldwide, yet many areas of its pathogenesis remain unknown or poorly understood, leaving potential for novel preventive and therapeutic interventions. Recent major advances in genomic science and technology have opened new avenues of investigation in the pathogenesis of CHD, some of which are leading to clinical translation. The published literature in CHD genetics has burgeoned in the last 5 years with the reporting of genome-wide association studies (GWASs) and many other findings. Identification of many genetic variants with small effects on CHD risk has been a common finding. These have included several predicted loci, such as those involved in conventional CHD risk factors (e.g. plasma lipids) and many novel loci, where their mechanism of action is unclear. The need for large, collaborative approaches to research has also become clear and is now an accepted modus operandi. The clinical utility of novel GWAS findings remains uncertain. In particular, the relative contribution of common variants of modest effect and rare variants of larger effects to risk of CHD or response to drugs is unclear. As a greater number of larger GWASs are conducted in CHD and its related ...Continue Reading

References

Jan 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·L F SoriaB J McCarthy
Aug 8, 1970·Nature·F Crick
May 29, 1998·The New England Journal of Medicine·A Tybjaerg-HansenB G Nordestgaard
Feb 19, 1999·Lancet·D M Lloyd-JonesD Levy
Feb 22, 2001·Science·J C VenterX Zhu
Mar 10, 2001·Nature·E S LanderUNKNOWN International Human Genome Sequencing Consortium
Dec 20, 2003·Nature·UNKNOWN International HapMap Consortium
Jan 17, 2004·Human Genetics·Kirsten M TimmsDonna M Shattuck
Apr 13, 2004·International Journal of Epidemiology·George Davey Smith, Shah Ebrahim
Jun 17, 2004·Seminars in Vascular Medicine·Miguel PocoviPedro Mata
Dec 6, 2005·Lancet·Aroon Hingorani, Steve Humphries
Mar 28, 2006·International Journal of Epidemiology·Juan P CasasAroon D Hingorani
Jul 28, 2006·International Journal of Epidemiology·Bernard KeavneyRory Collins
May 5, 2007·Science·Anna HelgadottirKari Stefansson
May 5, 2007·Science·Ruth McPhersonJonathan C Cohen
Jun 8, 2007·Nature·UNKNOWN Wellcome Trust Case Control Consortium
Jul 20, 2007·The New England Journal of Medicine·David J Hunter, Peter Kraft
Jul 20, 2007·The New England Journal of Medicine·Nilesh J SamaniUNKNOWN WTCCC and the Cardiogenics Consortium
Sep 22, 2007·Statistics in Medicine·Debbie A LawlorGeorge Davey Smith
Oct 16, 2007·Nature Methods·Thomas J AlbertRichard A Gibbs
Feb 8, 2008·The New England Journal of Medicine·Simon MallalUNKNOWN PREDICT-1 Study Team
Feb 19, 2008·Genetics in Medicine : Official Journal of the American College of Medical Genetics·David A FlockhartUNKNOWN ACMG Working Group on Pharmacogenetic Testing of CYP2C9, VKORC1 Alleles for Warfarin Use
Apr 29, 2008·American Journal of Human Genetics·Alexander P ReinerRonald M Krauss
May 30, 2008·Nature Genetics·Walter Bodmer, Carolina Bonilla
Jul 5, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Nilesh J SamaniTerho Lehtimäki
Jul 25, 2008·The New England Journal of Medicine·UNKNOWN SEARCH Collaborative GroupR Collins
Jul 31, 2008·Nature Genetics·Colleen M McBrideLawrence C Brody
Aug 30, 2008·BMJ : British Medical Journal·Anthony S WierzbickiUNKNOWN Guideline Development Group
Jul 2, 2009·JAMA : the Journal of the American Medical Association·Paul ElliottJaspal S Kooner
Jul 14, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Olga JarinovaRuth McPherson
Sep 1, 2009·The New England Journal of Medicine·Stuart J ConnollyUNKNOWN RE-LY Steering Committee and Investigators
Oct 9, 2009·Nature·Teri A ManolioPeter M Visscher
Oct 22, 2009·Clinical Genetics·A TaylorG Norbury
Nov 17, 2009·American Journal of Human Genetics·Philippa J TalmudUNKNOWN BRIGHT Consortium
Dec 25, 2009·The New England Journal of Medicine·Robert ClarkeUNKNOWN PROCARDIS Consortium
Feb 18, 2010·JAMA : the Journal of the American Medical Association·Nina P PaynterPaul M Ridker

❮ Previous
Next ❯

Citations

Jan 19, 2013·Journal of Thrombosis and Thrombolysis·Jiangfang LianShiwei Duan
Jul 3, 2013·Neurourology and Urodynamics·Ho-Mei ChenShiu-Dong Chung
Aug 19, 2015·Biochemical and Biophysical Research Communications·Peng JianqiangGuo Ying
Apr 30, 2013·Progress in Cardiovascular Diseases·Jennifer Gladys Mulle, Viola Vaccarino
Jun 6, 2015·BMC Medical Genomics·Mani P GroverMerridee A Wouters
Sep 20, 2016·Journal of Hepatology·Markus H HeimJacob George
Apr 29, 2014·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Jo B MiddlemassNadeem Qureshi
Jun 11, 2014·Molecular Biology Reports·Fei ChenDuan Ma
Aug 26, 2016·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Jing-Fang LiYong Yin
Jul 3, 2021·Cells·Cherrie D ShermanSusmita Sahoo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.